{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:40:23Z","timestamp":1794062423004,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To examine the relationship between coronavirus disease 2019 (COVID-19) diagnosis at delivery and adverse maternal health and pregnancy outcomes during pre-Delta, Delta, and Omicron variant predominance, with a focus on the time period of Omicron variant predominance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a cross-sectional observational study with data from delivery hospitalizations in the Premier Healthcare Database from February 2020 to August 2023. The pre-Delta (February 2020\u2013June 2021), Delta (July 2021\u2013December 2021), and Omicron (January 2022\u2013August 2023) periods of variant predominance were examined. Exposure to COVID-19 was identified by having a diagnostic code for COVID-19 during the delivery hospitalization. Adjusted prevalence ratios (aPRs) were calculated to compare the risks of adverse maternal and pregnancy outcomes for women with and without COVID-19 diagnoses at the time of delivery for each variant period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Among 2,990,973 women with delivery hospitalizations, 1.9% (n=56,618) had COVID-19 diagnoses noted at delivery admission discharge, including 26,053 during the Omicron period. Across all variant time periods, the prevalence of many adverse maternal and pregnancy outcomes during the delivery hospitalization was significantly higher for pregnant women with COVID-19 compared with pregnant women without COVID-19. In adjusted models, COVID-19 during the Omicron period was associated with significant increased risks for maternal sepsis (COVID-19: 0.4% vs no COVID-19: 0.1%; aPR 3.32, 95% CI, 2.70\u20134.08), acute respiratory distress syndrome (0.6% vs 0.1%; aPR 6.19, 95% CI, 5.26\u20137.29), shock (0.2% vs 0.1%; aPR 2.14, 95% CI, 1.62\u20132.84), renal failure (0.5% vs 0.2%; aPR 2.08, 95% CI, 1.73\u20132.49), intensive care unit admission (2.7% vs 1.7%; aPR 1.64, 95% CI, 1.52\u20131.77), mechanical ventilation (0.3% vs 0.1%; aPR 3.15, 95% CI, 2.52\u20133.93), in-hospital death (0.03% vs 0.01%; aPR 5.00, 95% CI, 2.30\u201310.90), stillbirth (0.7% vs 0.6%; aPR 1.17, 95% CI, 1.01\u20131.36), and preterm delivery (12.3% vs 9.6%; aPR 1.28, 95% CI, 1.24\u20131.33).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Despite the possibility of some level of immunity due to previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, vaccination, or testing differences, risks of adverse outcomes associated with COVID-19 diagnosis at delivery remained elevated during the Omicron variant time period.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005449","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T17:22:58Z","timestamp":1698945778000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Pre-Delta, Delta, and Omicron Periods of the Coronavirus Disease 2019 (COVID-19) Pandemic and Health Outcomes During Delivery Hospitalization"],"prefix":"10.1097","volume":"143","author":[{"given":"Jeffrey","family":"Carlson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina M.","family":"Simeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Ellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romeo","family":"Galang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla L.","family":"DeSisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Fleming-Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Meaney-Delman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van T.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"m3320","DOI":"10.1136\/bmj.m3320","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22\u2013October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"S781","DOI":"10.1016\/j.ajog.2022.11.133","article-title":"Pregnancy outcomes by pandemic wave among pregnant individuals with COVID-19 infection [abstract]","volume":"228","author":"Craig","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.15585\/mmwr.mm7047e1","article-title":"Risk for stillbirth among women with and without COVID-19 at delivery hospitalization\u2014United States, March 2020\u2013September 2021","volume":"70","author":"DeSisto","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"100569","DOI":"10.1016\/j.lanepe.2022.100569","article-title":"Maternal and perinatal outcomes following pre-Delta, Delta, and Omicron SARS-CoV-2 variants infection among unvaccinated pregnant women in France and Switzerland: a prospective cohort study using the COVI-PREG registry","volume":"26","author":"Favre","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"S782","DOI":"10.1016\/j.ajog.2022.11.135","article-title":"Disease severity across pandemic waves among pregnant individuals with COVID-19 [abstract]","volume":"228","author":"Judge-Golden","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajic.2022.07.023","article-title":"Impact of vaccination and the Omicron variant on COVID-19 severity in pregnant women","volume":"51","author":"Kim","year":"2023","journal-title":"Am J Infect Control"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jiac.2022.09.005","article-title":"Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods","volume":"29","author":"Shoji","year":"2023","journal-title":"J Infect Chemother"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"o358","DOI":"10.1136\/bmj.o358","article-title":"Covid-19: what do we know about Omicron sublineages?","volume":"376","author":"Mahase","year":"2022","journal-title":"BMJ"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S2213-2600(22)00360-5","article-title":"Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by Delta and Omicron variants in Scotland: a population-based cohort study","volume":"10","author":"Stock","year":"2022","journal-title":"Lancet Respir Med"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(22)02467-9","article-title":"Pregnancy outcomes and vaccine effectiveness during the period of Omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study","volume":"401","author":"Villar","year":"2023","journal-title":"Lancet"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"100712","DOI":"10.1016\/j.ajogmf.2022.100712","article-title":"Preterm birth and severe maternal morbidity associated with SARS-CoV-2 infection during the Omicron wave","volume":"4","author":"Gulersen","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/AOG.0000000000004849","article-title":"Maternal and perinatal outcomes associated with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"140","author":"Seasely","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"suppl 1","key":"R15-20260916","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/cid\/ciab344","article-title":"Adverse pregnancy outcomes, maternal complications, and severe illness among US delivery hospitalizations with and without a coronavirus disease 2019 (COVID-19) diagnosis","volume":"73","author":"Ko","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41372-022-01327-3","article-title":"Changes in rates of adverse pregnancy outcomes during the COVID-19 pandemic: a cross-sectional study in the United States, 2019\u20132020","volume":"42","author":"Simeone","year":"2022","journal-title":"J Perinatol"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) variants\u2014United States, June 2021\u2013January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.15585\/mmwr.mm7137a4","article-title":"Mortality risk among patients hospitalized primarily for COVID-19 during the Omicron and Delta variant pandemic periods\u2014United States, April 2020\u2013June 2022","volume":"71","author":"Adjei","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"e231181","DOI":"10.1001\/jamanetworkopen.2023.1181","article-title":"Acute and postacute COVID-19 outcomes among immunologically naive adults during Delta vs Omicron waves","volume":"6","author":"Doll","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/uog.24916","article-title":"Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves","volume":"60","author":"Birol Ilter","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"e2233273","DOI":"10.1001\/jamanetworkopen.2022.33273","article-title":"Estimation of COVID-19 mRNA vaccine effectiveness against medically attended COVID-19 in pregnancy during periods of Delta and Omicron variant predominance in the United States","volume":"5","author":"Schrag","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"463","DOI":"10.15585\/mmwr.mm7217a3","article-title":"Effectiveness of monovalent mRNA COVID-19 vaccination in preventing COVID-19\u2013associated invasive mechanical ventilation and death among immunocompetent adults during the Omicron variant period\u2014IVY network, 19 U.S. states, February 1, 2022\u2013January 31, 2023","volume":"72","author":"DeCuir","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.15585\/mmwr.mm7148e1","article-title":"Effectiveness of bivalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection\u2014increasing community access to testing program, United States, September\u2013November 2022","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","article-title":"Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status\u2014United States, April 2021\u2013September 2022","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"523","DOI":"10.15585\/mmwr.mm7219e1","article-title":"COVID-19 surveillance after expiration of the public health emergency declaration\u2015United States, May 11, 2023","volume":"72","author":"Silk","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ogc.2023.02.003","article-title":"Safety and effectiveness of maternal COVID-19 vaccines among pregnant people and infants","volume":"50","author":"Fleming-Dutra","year":"2023","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"657","DOI":"10.15585\/mmwr.mm7224a3","article-title":"Interim recommendations for use of bivalent mRNA COVID-19 vaccines for persons aged \u22656 months\u2014United States, April 2023","volume":"72","author":"Moulia","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:14Z","timestamp":1789556474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005449","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3346406\/v1","asserted-by":"object"}]},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"2023-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}